9:20 am-10:40 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Upendra Kaul |
Discussant |
|
9:20 am-10:40 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Tian-Hai Koh |
Discussant |
|
9:20 am-10:40 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Jian Liu |
Discussant |
|
9:20 am-9:25 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
William Wijns |
Lecturer |
Introduction and Objectives |
9:25 am-9:35 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Yuejin Yang |
Lecturer |
How Did We Treat Left Main Disease Before NOBLE and EXCEL? |
9:45 am-9:55 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Patrick W. Serruys |
Lecturer |
A Trialist’s View on NOBLE and EXCEL: What Do They Add? |
10:05 am-10:10 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Huay Cheem Tan |
Lecturer |
How Should I Treat This Patient with LM Disease? |
10:10 am-10:15 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Junjie Zhang |
Lecturer |
How Would I Treat This Patient with LM Disease? |
10:15 am-10:20 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Rosli Mohd Ali |
Lecturer |
How Would I Treat This Patient with LM Disease? |
10:25 am-10:30 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Huay Cheem Tan |
Lecturer |
How Did I Treat This Patient with LM Disease? |
10:35 am-10:40 am, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session II: PCI for Left Main Disease - Do NOBLE and EXCEL Change Our Practice?
|
Shaoliang Chen |
Lecturer |
Take-Home Message |
10:40 am-12:00 pm, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session III: Live Cases III
|
Christoph K. Naber |
Moderator |
|
10:40 am-12:00 pm, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session III: Live Cases III
|
Bo Xu |
Moderator |
|
10:40 am-12:00 pm, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session III: Live Cases III
|
Jung-Min Ahn |
Discussant |
|
10:40 am-12:00 pm, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session III: Live Cases III
|
Andreas Baumbach |
Discussant |
|
10:40 am-12:00 pm, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session III: Live Cases III
|
Mao Chen |
Discussant |
|
10:40 am-12:00 pm, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session III: Live Cases III
|
Michael Haude |
Discussant |
|
10:40 am-12:00 pm, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session III: Live Cases III
|
Marie-Claude Morice |
Discussant |
|
10:40 am-12:00 pm, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session III: Live Cases III
|
Teguh Santoso |
Discussant |
|
10:40 am-12:00 pm, Saturday, April 1, 2017
|
Ballroom ABC, Level 1 |
Plenary Sessions
PCR at CIT
Session III: Live Cases III
|
Wei-Hsian Yin |
Discussant |
|
Records:212 Pre[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[10]
[11]
Next |